n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with pinacidil in 3 studies
Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (pinacidil) | Trials (pinacidil) | Recent Studies (post-2010) (pinacidil) |
---|---|---|---|---|---|
214 | 5 | 58 | 1,059 | 41 | 125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Liang, BT | 1 |
Elliott, GT; Jacobson, KA; Liang, BT; Stambaugh, K | 1 |
3 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and pinacidil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection.
Topics: Adenosine; Animals; Cells, Cultured; Chick Embryo; Enzyme Activation; Glyburide; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Myocardium; Pinacidil; Potassium Channels; Protein Kinase C; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Tetradecanoylphorbol Acetate | 1998 |
Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel.
Topics: Adenosine; Animals; Cells, Cultured; Chick Embryo; Ischemic Preconditioning, Myocardial; Lipid A; Myocardium; omega-N-Methylarginine; Pinacidil; Potassium Channels; Purinergic P1 Receptor Agonists; Vasodilator Agents | 1999 |